{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:09Z","timestamp":1759403409165,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.08.061","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:17:45Z","timestamp":1567790265000},"page":"6248-6254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6106-7490","authenticated-orcid":false,"given":"Marcia A.","family":"Blackman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hepburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-7248","authenticated-orcid":false,"given":"Bruce L.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent E.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Cristina","family":"Cassetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Saville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.08.061_b0005","unstructured":"Shattuck lecture. Bill and Melinda Gates Foundation. <https:\/\/www.gatesfoundation.org\/Media-Center\/Speeches\/2018\/04\/Shattuck-Lecture-Innovation-for-Pandemics> [accessed April 2019]."},{"key":"10.1016\/j.vaccine.2019.08.061_b0010","unstructured":"CDC centers for disease control and prevention. Ebola. <https:\/\/www.cdc.gov\/vhf\/ebola\/history\/2014-2016-outbreak\/case-counts.html> [accessed April 2019]."},{"key":"10.1016\/j.vaccine.2019.08.061_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4161\/org.28918","article-title":"In vitro organogenesis from pluripotent stem cells","volume":"10","author":"Li","year":"2014","journal-title":"Organogenesis"},{"key":"10.1016\/j.vaccine.2019.08.061_b0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2016.11.017","article-title":"Induction of expansion and folding in human cerebral organoids","volume":"20","author":"Li","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.vaccine.2019.08.061_b0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s13238-017-0479-2","article-title":"Recapitulating cortical development with organoid culture in vitro and modeling abnormal spindle-like (ASPM related primary) microcephaly disease","volume":"8","author":"Li","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.vaccine.2019.08.061_b0030","first-page":"20","article-title":"Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic","volume":"18","author":"Graham","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.08.061_b0035","doi-asserted-by":"crossref","first-page":"e1006994","DOI":"10.1371\/journal.ppat.1006994","article-title":"Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection","volume":"14","author":"Szaba","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.08.061_b0040","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1073\/pnas.1600996113","article-title":"Monoclonal antibody therapy for Junin virus infection","volume":"113","author":"Zeitlin","year":"2016","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.08.061_b0045","doi-asserted-by":"crossref","first-page":"e0004866","DOI":"10.1371\/journal.pntd.0004866","article-title":"Novel ordered stepped-wedge cluster trial designs for detecting ebola vaccine efficacy using a spatially structured mathematical model","volume":"10","author":"Diakite","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.08.061_b0050","first-page":"h3740","article-title":"The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola","volume":"351","author":"Ebola ca Suffit Ring Vaccination Trial Consortium","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.08.061_b0055","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1099\/vir.0.059436-0","article-title":"Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2","volume":"94","author":"Li","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.08.061_b0060","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1128\/JVI.00480-13","article-title":"An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody","volume":"87","author":"Petrovsky","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.08.061_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vetmic.2013.05.026","article-title":"Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge","volume":"166","author":"Sun","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.061_b0070","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1016\/j.vaccine.2012.04.099","article-title":"Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine","volume":"30","author":"Partidos","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:14Z","timestamp":1759401314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19311375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":14,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0264410X19311375"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}